Skip to main content

ZIMMER BIOMET HOLDINGS, INC. (ZBH) Stock Forecast 2025 - AI Price Prediction & Analysis


ZIMMER BIOMET HOLDINGS, INC. (ZBH) AI Stock Price Forecast & Investment Analysis

ZIMMER BIOMET HOLDINGS, INC. Stock Price Chart and Technical Analysis

Loading ZIMMER BIOMET HOLDINGS, INC. interactive price chart and technical analysis...

ZIMMER BIOMET HOLDINGS, INC. (ZBH) - Comprehensive Stock Analysis & Investment Research

Deep dive into ZIMMER BIOMET HOLDINGS, INC.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about ZIMMER BIOMET HOLDINGS, INC., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For ZIMMER BIOMET HOLDINGS, INC.: ZIMMER BIOMET HOLDINGS, INC. operates in the Industrial Applications and Services sector, positioning it as a large-cap market leader.

ZIMMER BIOMET HOLDINGS, INC. (Stock Symbol: ZBH) is a leading company in the Industrial Applications and Services sector , specifically operating within the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry.

The organization employs approximately 16972 professionals worldwide .

The company has established itself as a major market leader with significant institutional backing.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing ZIMMER BIOMET HOLDINGS, INC.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For ZIMMER BIOMET HOLDINGS, INC.: With $7833M in annual revenue and 2.8% net margin, the company demonstrates developing profitability.

Annual Revenue: $7833 million generating a 2.8% net profit margin .

Market Capitalization: $19884 million - Classified as a large-cap stock with institutional-grade stability.

Return on Equity (ROE): 1.8% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for ZIMMER BIOMET HOLDINGS, INC. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For ZIMMER BIOMET HOLDINGS, INC.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for ZIMMER BIOMET HOLDINGS, INC. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: ZIMMER BIOMET HOLDINGS, INC.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For ZIMMER BIOMET HOLDINGS, INC.: Strong free cash flow generation demonstrates exceptional operational efficiency.

ZIMMER BIOMET HOLDINGS, INC. strategically competes in the highly dynamic Orthopedic, Prosthetic & Surgical Appliances & Supplies marketplace, positioning itself as a dominant large-cap market leader with significant competitive moats and institutional investor confidence .

The company demonstrates robust operational efficiency through strong free cash flow generation of $1299 million annually, complemented by impressive -24.0% year-over-year cash flow growth.

The company maintains a healthy 69.6% gross margin, indicating strong pricing power and operational efficiency.

ZIMMER BIOMET HOLDINGS, INC. (ZBH) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for ZIMMER BIOMET HOLDINGS, INC. stock analysis.

Loading ZIMMER BIOMET HOLDINGS, INC. comprehensive fundamental analysis and insider trading data...

Deep dive into ZIMMER BIOMET HOLDINGS, INC.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if ZIMMER BIOMET HOLDINGS, INC. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For ZIMMER BIOMET HOLDINGS, INC.: With a P/E ratio of 24.15, the market moderately values the company's earnings.

P/E Ratio 24.15x
P/B Ratio 1.59x
Market Cap $19884M
Dividend Yield 0.96%
EPS $4.12
Book Value/Share $62.92
Revenue/Share $39.37
FCF/Share $5.12
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently ZIMMER BIOMET HOLDINGS, INC. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For ZIMMER BIOMET HOLDINGS, INC.: An ROE of 1.8% indicates room for improvement in shareholder value creation.

ROE 1.8%
ROA 1.0%
ROIC 2.1%
Gross Margin 69.6%
Operating Margin 12.2%
Net Margin 2.8%
EBT Margin 3.9%
Tax Rate 7.6%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess ZIMMER BIOMET HOLDINGS, INC.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For ZIMMER BIOMET HOLDINGS, INC.: A current ratio of 1.69 shows adequate liquidity.

Current Ratio 1.69x
Quick Ratio 0.63x
D/E Ratio 0.45x
Financial Leverage 1.80x
Interest Coverage 2.6x
Working Capital $2526M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal ZIMMER BIOMET HOLDINGS, INC.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For ZIMMER BIOMET HOLDINGS, INC.: Free cash flow of $1299M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $1490M
Free Cash Flow $1299M
Capital Spending $-191M
OCF Growth YoY -24.0%
FCF Growth YoY -8.0%
FCF/Sales 16.5%
CapEx/Sales 2.4%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively ZIMMER BIOMET HOLDINGS, INC. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For ZIMMER BIOMET HOLDINGS, INC.: An asset turnover of 0.35x suggests room for improvement in asset utilization.

Asset Turnover 0.35x
Receivables Turnover 6.0x
Inventory Turnover 1.0x
Fixed Assets Turnover 4.1x
Days Sales Outstanding 61 days
Days Inventory 352 days
Payables Period 49 days
Cash Conversion Cycle 364 days
Understanding Financial Statement Data

What these metrics mean: Key figures from ZIMMER BIOMET HOLDINGS, INC.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For ZIMMER BIOMET HOLDINGS, INC.: With annual revenue of $7833M, ZIMMER BIOMET HOLDINGS, INC. operates at significant scale.

Income Statement ($ Millions)
Total Revenue $7833M
R&D Expense $54M
SG&A Expense $42M
Cost of Goods Sold $2143M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 21%
Cash & Short-term Investments 2%
Total Liabilities 44%
Short-term Debt 5%
Accounts Receivable 6%
Inventory 10%
Dividend & Shareholder Information
Dividends Per Share $0.96
Payout Ratio 0.2%
Shares Outstanding 199M
Growth Metrics (YoY)
EPS Growth 5.2%

Latest ZIMMER BIOMET HOLDINGS, INC. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting ZIMMER BIOMET HOLDINGS, INC. (ZBH) stock price and investment outlook.

, source: Insider Monkey

Scout Investments, Inc., an affiliate of Carillon Tower Advisers, released the “Carillon Scout Mid Cap Fund” second quarter 2025 investor letter. A copy of the letter can be downloaded here. The ...

, source: Seeking Alpha

Deal Strengthens Zimmer Biomet's Growing Sports Medicine Portfolio and Supports Continued Company Transformation WARSAW, Ind., Jan. 5, 2023 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (ZBH), a global ...

, source: Business Insider

More Bonds of Zimmer Biomet Holdings Inc. Moody’s Daily Credit Risk Score About the Zimmer Biomet Holdings Inc.-Bond (US98956PBA93) The Zimmer Biomet Holdings Inc.-Bond has a maturity date of ...

, source: Business Insider

More Bonds of Zimmer Biomet Holdings Inc. Moody’s Daily Credit Risk Score About the Zimmer Biomet Holdings Inc.-Bond (US98956PBC59) The Zimmer Biomet Holdings Inc.-Bond has a maturity date of ...

ZIMMER BIOMET HOLDINGS, INC. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of ZIMMER BIOMET HOLDINGS, INC. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ALGN Unlock Forecast - 30 Days FREE Trial $9412M 21.5x 2.4x
APT Unlock Forecast - 30 Days FREE Trial $48M 13.5x 0.8x
AVNS Unlock Forecast - 30 Days FREE Trial $530M 100.0x 0.7x
AVR Unlock Forecast - 30 Days FREE Trial $176M x 7.2x
CDRE Unlock Forecast - 30 Days FREE Trial $1640M 43.0x 4.9x
CLGN Unlock Forecast - 30 Days FREE Trial $30M x 2.4x
ENOV Unlock Forecast - 30 Days FREE Trial $1766M -23.9x 0.7x
ESTA Unlock Forecast - 30 Days FREE Trial $1369M -15.4x 60.2x
EW Unlock Forecast - 30 Days FREE Trial $42711M 10.3x 4.1x
INGN Unlock Forecast - 30 Days FREE Trial $226M -2.8x 1.1x
ISRG Unlock Forecast - 30 Days FREE Trial $155768M 59.7x 8.7x
LAKE Unlock Forecast - 30 Days FREE Trial $152M 742.3x 1.0x
LFWD Unlock Forecast - 30 Days FREE Trial $11M -2.5x 0.7x
LGMK Unlock Forecast - 30 Days FREE Trial $2M -0.3x 0.1x
MLSS Unlock Forecast - 30 Days FREE Trial $35M -7.1x 10.4x
MNESP Unlock Forecast - 30 Days FREE Trial $1761M 6.4x 2.1x
MSA Unlock Forecast - 30 Days FREE Trial $6460M 23.3x 7.7x
MYO Unlock Forecast - 30 Days FREE Trial $39M -26.3x 2.2x
NAOV Unlock Forecast - 30 Days FREE Trial $5M -0.5x 0.1x
POAI Unlock Forecast - 30 Days FREE Trial $92M -2.5x -48.4x
RBOT Unlock Forecast - 30 Days FREE Trial $35M -4.2x 1.5x
SMTI Unlock Forecast - 30 Days FREE Trial $252M -37.5x 7.1x
SPAI Unlock Forecast - 30 Days FREE Trial $138M x 53.6x
STE Unlock Forecast - 30 Days FREE Trial $23670M 36.6x 3.4x
ZBH Unlock Forecast - 30 Days FREE Trial $19884M 24.2x 1.6x

Frequently Asked Questions - ZIMMER BIOMET HOLDINGS, INC. Stock Forecast

How accurate are ZIMMER BIOMET HOLDINGS, INC. stock predictions?

Our AI model demonstrates 59% historical accuracy for ZBH predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence ZIMMER BIOMET HOLDINGS, INC. stock price forecasts?

Our analysis considers ZIMMER BIOMET HOLDINGS, INC.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is ZIMMER BIOMET HOLDINGS, INC. a good investment in 2025?

Based on our AI analysis, ZIMMER BIOMET HOLDINGS, INC. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are ZIMMER BIOMET HOLDINGS, INC. forecasts updated?

ZIMMER BIOMET HOLDINGS, INC. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced ZIMMER BIOMET HOLDINGS, INC. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for ZIMMER BIOMET HOLDINGS, INC. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...